|
| | (8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid Basic information |
| Product Name: | (8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid | | Synonyms: | (8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid;5,6-DHET;(8Z,11Z,14Z)-5,6-Dihydroxy-8,11,14-icosatrienoic acid;(±)5(6)-DiHET;GFNYAPAJUNPMGH-QNEBEIHSSA-N;(5(6)-DiHET MaxSpecStandard;5,6-dihydroxyicosa-8,11,14-trienoic acid;8,11,14-Eicosatrienoic acid, 5,6-dihydroxy-, (8Z,11Z,14Z)- | | CAS: | 213382-49-1 | | MF: | C20H34O4 | | MW: | 338.48 | | EINECS: | | | Product Categories: | | | Mol File: | 213382-49-1.mol |  |
| | (8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid Chemical Properties |
| Boiling point | 515.2±50.0 °C(Predicted) | | density | 1.025±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: 50 mg/ml; DMSO: 50 mg/ml; Ethanol: 50 mg/ml; PBS pH 7.2: 1 mg/ml | | pka | 4.68±0.10(Predicted) |
| | (8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid Usage And Synthesis |
| Uses | (±)?-5,?6-?Dihydroxy-?8Z,?11Z,?14Z-?eicosatrienoic Acid ((±)?5,?6-DHET) is associated with abnormal lipoprotein oxylipins and metabolic disorders and may contribute to chronic inflammation. | | Definition | ChEBI: A DHET obtained by formal dihydroxylation across the 5,6-double bond of arachidonic acid. |
| | (8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid Preparation Products And Raw materials |
|
